DCVC (Data Collective)

DCVC (Data Collective)
Name	Data Collective
Trade name	DCVC
Founded	2011
Founders	Matt Ocko; Zachary Bogue
Headquarters	San Francisco, California
Industry	Venture capital
Products	Venture capital funds; growth equity

DCVC (Data Collective) is a venture capital firm founded in 2011 that specializes in deep technology and science-driven startups. The firm focuses on companies applying advanced computing, biological engineering, robotics, and materials science to transform established industries and create new markets. DCVC has been involved across multiple funding stages and is known for backing ventures that intersect with domains like artificial intelligence, biotechnology, aerospace, and energy.

History

DCVC was founded by Matt Ocko and Zachary Bogue in 2011 amid a wave of Silicon Valley activity that included entities such as Andreessen Horowitz, Sequoia Capital, Kleiner Perkins, and Benchmark (venture capital firm). Early years featured partnerships with technology incubators and research institutions similar to Y Combinator, Harvard University, Stanford University, and Massachusetts Institute of Technology. The firm grew its profile alongside contemporaries like First Round Capital and Accel Partners and expanded its presence during the 2010s alongside sovereign and corporate venture investors such as SoftBank Group and GV (company). DCVC’s trajectory intersected with public market events involving companies like Alphabet Inc., Tesla, Inc., Amazon (company), and Microsoft as its portfolio evolved.

Investment Focus and Strategy

DCVC pursues investments at the intersection of high-performance computing and the life sciences, echoing themes seen with organizations such as OpenAI, DeepMind, Genentech, and Illumina. The firm emphasizes backing teams developing technologies comparable to innovations from SpaceX, Blue Origin, Palantir Technologies, and NVIDIA Corporation. DCVC’s strategy includes early-stage seed and Series A deals as well as follow-on participation in later rounds alongside growth investors like Tiger Global Management, SoftBank Vision Fund, and Coatue Management. The firm’s thesis aligns with sectors represented by CRISPR Therapeutics, Moderna, Ginkgo Bioworks, and Rigetti Computing, focusing on platform companies that can scale commercially.

Notable Investments and Portfolio Companies

DCVC’s portfolio spans companies in artificial intelligence, biotechnology, robotics, and climate-tech. Notable investments include ventures with parallels to Planet Labs, Anduril Industries, Sana Biotechnology, Pivot Bio, and Commonwealth Fusion Systems. The firm has backed startups working on synthetic biology platforms similar to Amyris, Zymergen, and Conagen, and AI-backed drug discovery companies akin to Insitro, Atomwise, and BenevolentAI. DCVC’s aerospace- and defense-adjacent investments recall actors such as Rocket Lab USA, Relativity Space, and Northrop Grumman, while its climate and energy bets evoke projects by Tesla, Inc., Bloom Energy, and Form Energy. Portfolio coordination and exits have involved public listings and acquisitions in markets dominated by players like Intel Corporation, Johnson & Johnson, Pfizer, Thermo Fisher Scientific, and Boeing.

Fund Structure and Financial Performance

DCVC raises closed-end venture funds, following structures similar to those managed by Sequoia Capital and Accel Partners, with limited partners that often include university endowments like Harvard Management Company, Yale Investments Office, and Stanford Management Company, as well as family offices and corporate limited partners comparable to Temasek Holdings and Norwegian Sovereign Wealth Fund. Performance metrics and reported internal rates of return are discussed in the context of comparable funds from Andreessen Horowitz, Benchmark (venture capital firm), and Lightspeed Venture Partners. DCVC participates in priced equity rounds, convertible notes, and SAFEs in line with market practices typified by Y Combinator startups and growth financings led by SoftBank Group and Tiger Global Management.

Leadership and Key Personnel

Founders Matt Ocko and Zachary Bogue anchor the firm’s leadership; other senior figures and investment partners have backgrounds similar to executives from Google LLC, Facebook, Apple Inc., Intel Corporation, NASA, and academic connections to Massachusetts Institute of Technology, Stanford University, and University of California, Berkeley. Board interactions and operating partners often mirror governance practices seen at companies like Palantir Technologies and Stripe (company), and DCVC’s ecosystem includes advisors with ties to institutions such as DARPA, NIH, and NASA.

Criticism and Controversies

As with several venture firms, DCVC has faced scrutiny related to portfolio company governance, exit valuations, and relationships with defense and government-affiliated programs, issues that have also affected firms including Andreessen Horowitz, Sequoia Capital, and SoftBank Group. Debates around investment in surveillance-adjacent, bioengineering, and military-adjacent technologies echo controversies seen with companies like Palantir Technologies, Clearview AI, Theranos, and debates involving DARPA partnerships. Questions about concentration risk, fund performance, and limited partner disclosures have parallels in public discussions about WeWork, Uber Technologies, and Snap Inc..

Category:Venture capital firms in the United States